Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antineoplastic new usage of cardiac glycoside compound in antiar

A technology of cardiac glycosides and compounds, applied in the field of medicine, can solve the problem of no inhibition of tumor cell activity

Inactive Publication Date: 2008-04-09
INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI
View PDF0 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There have been reports on the cardiotonic effect of the cardiac glycosides isolated from Jianxuefenghou, but no reports on the inhibition of tumor cell activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antineoplastic new usage of cardiac glycoside compound in antiar
  • Antineoplastic new usage of cardiac glycoside compound in antiar
  • Antineoplastic new usage of cardiac glycoside compound in antiar

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0013] Example 1: Cardiac glycoside compounds toxicarioside A (toxicarioside A), α-antiaroside (α-antiarin), see the extraction and separation of antiarojavoside:

[0014] See blood seal throat milk (4L) with 95% ethanol at room temperature leaching 3 times, and recover ethanol under reduced pressure until it has no alcohol smell. The ethanol extract was dispersed in water to form a suspension, extracted with petroleum ether to obtain the petroleum ether part (6.87g), and then extracted with ethyl acetate to obtain the ethyl acetate part (8.69g), and the remaining aqueous solution was filtered and placed on the Macroporous adsorption resin (D-101) column chromatography, eluting with water and methanol successively, collecting the methanol eluate, and concentrating to obtain the methanol fraction (228.4g). The obtained ethyl acetate part and the methanol part were divided into several fractions through a decompression column respectively, and then repeated column chromatography...

Embodiment 2

[0015] Example 2: Structural identification of cardiac glycosides toxicarioside A (toxicarioside A), α-antiarojarin, and antiarojavoside:

[0016] Utilizing spectroscopic techniques, including ultraviolet, infrared, nuclear magnetic resonance and high-resolution mass spectrometry, the cardiac glycosides in Example 1 were identified as toxoside, α-toxoside, and toxoside. Structure. For the first time, 2D-NMR technology was used to analyze certain compounds, such as the sugars on sugars such as blood seal throat java glycosides. 13 C-NMR, 1 H-NMR data were assigned. (see Attachment 1, 2)

Embodiment 3

[0017] Example 3: Cardiac glycoside compounds toxicarioside A (toxicarioside A), α-antiarojavoside (α-antiarin), antiarojavoside in vitro tumor inhibition experiment:

[0018] MTT method was used to test the effects of cardiac glycosides Dujianxuefengroside A, α-seexuefengyroside, and Xuefengyaoside on human liver cancer cells SMMC-7721, gastric cancer cells SGC-7901, and breast cancer cells. In vitro tumor inhibitory activity of MCF-7 and chronic myelogenous leukemia cells K562 (see attached table 3 for results). Activity testing method is as follows: experiment is established negative control group (water), DMSO solvent control group, positive control group (mitomycin C) and 8 different concentrations (0.8,1.6,3.2,6.3,12.5,25,50,100 ) of the samples to be tested, two parallels were set for each concentration. Cells in the logarithmic growth phase were collected, counted on a hemocytometer, and inoculated in a 96-well flat-bottomed cell culture plate according to the amount ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the medicine technology field, in particular relates to a new application of cardiac glycoside chemical compound having general formula (I) in preparing oncotherapy drug, wherein, R equals to 2-O-methyl-Beta-D-mycose, 6-deoxidation-Beta-D-gulose or 6-deoxidation-2-O-methyl-Beta-D-allose. The cardiac glycoside chemical compound can be obtained through a separation from upas in various conventional separation methods or be obtained through a synthesis or semisynthesis method.

Description

Technical field: [0001] The invention relates to the technical field of medicine, in particular to a new application of a class of cardiac glycoside compounds in the preparation of drugs for treating tumors. Background technique: [0002] See blood seal throat [Antiaris toxicaria (Pers.) Lesch.] is the plant of Moraceae see blood seal throat genus (Antiaris). Alternative names: Gabe, scissor tree, poison arrow wood. There are about 4 species and 3 varieties in the genus Bloodseal in the world, and they are distributed in Southeast Asia. Only one species is produced in our country, that is, blood seal throat, which is distributed in Hainan, Yunnan, Guangdong, Guangxi and other places. It is said to be one of the most poisonous tree species among woody plants in the world. It grows in the evergreen broad-leaved rainforest and monsoon rainforest in the mountains at an altitude of 300-1000m. The fresh tree sap is milky white and highly toxic. It is used as medicine for diarrh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7048A61P35/00
Inventor 戴好富梅文莉干玉娟
Owner INST OF TROPICAL BIOSCI & BIOTECH CHINESE ACADEMY OF TROPICAL AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com